X0306
4
2019-02-19
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001575745
Jovan-Embiricos Morana
C/O TCR2 THERAPEUTICS INC.
100 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
1
0
0001600769
Globeways Holdings Ltd
3RD FLOOR, GENEVE PLACE, WATERFRONT DR
PO BOX 3175, ROAD TOWN, TORTOLA, BVI
CH-1205 GENEVA
V8
SWITZERLAND
0
0
1
0
0001768161
Globeways Holdings II Ltd
3RD FLOOR, GENEVE PLACE, WATERFRONT DR
PO BOX 3175, ROAD TOWN TORTOLA, BVI
CH-1205 GENEVA
V8
SWITZERLAND
0
0
1
0
0001767391
F2 Capital I 2015 Ltd
C/O LJ PARTNERSHIP, 8, RUE
SAINT-LEGER,
GENEVA
V8
CH-1205
SWITZERLAND
0
0
1
0
0001767388
F2 Bioscience II 2017 Ltd
C/O LJ PARTNERSHIP, 8, RUE
SAINT-LEGER,
GENEVA
V8
CH-1205
SWITZERLAND
0
0
1
0
0001767390
F2 Captial I 2017 Ltd
C/O LJ PARTNERSHIP, 8, RUE
SAINT-LEGER,
GENEVA
V8
CH-1205
SWITZERLAND
0
0
1
0
0001767396
F2 MG Ltd
C/O LJ PARTNERSHIP, 8, RUE
SAINT-LEGER,
GENEVA
V8
CH-1205
SWITZERLAND
0
0
1
0
0001767397
F2 - TPO Investments LLC
C/O LJ PARTNERSHIP, 8, RUE
SAINT-LEGER,
GENEVA
V8
CH-1205
SWITZERLAND
0
0
1
0
0001767415
F2 BBG LLC
C/O SINGER MCKEON INC, 8 WEST 38TH ST
SUITE 1001
NEW YORK
NY
10018
0
0
1
0
0001767418
F2 Capital I 2019, LLC
C/O SINGER MCKEON INC, 8 WEST 38TH ST
SUITE 1001
NEW YORK
NY
10018
0
0
1
0
Common Stock
2019-02-19
4
C
0
1614515
A
1614515
I
By Fund
Common Stock
2019-02-19
4
C
0
193742
A
193742
I
By Fund
Common Stock
2019-02-19
4
C
0
410168
A
410168
I
By Fund
Common Stock
2019-02-19
4
C
0
282540
A
282540
I
By Fund
Common Stock
2019-02-19
4
C
0
403629
A
403629
I
By Fund
Common Stock
2019-02-19
4
P
0
200000
15.00
A
200000
I
By Fund
Common Stock
2019-02-19
4
P
0
166667
15.00
A
166667
I
By Fund
Common Stock
2019-02-19
4
P
0
166667
15.00
A
449207
I
By Fund
Common Stock
2019-02-19
4
P
0
133333
15.00
A
536962
I
By Fund
Series A Preferred Stock
2019-02-19
4
C
0
10000001
D
Common Stock
1614515
0
I
By Fund
Series B Preferred Stock
2019-02-19
4
C
0
1200000
D
Common Stock
193742
0
I
By Fund
Series B Preferred Stock
2019-02-19
4
C
0
2540500
D
Common Stock
410168
0
I
By Fund
Series B Preferred Stock
2019-02-19
4
C
0
1750000
D
Common Stock
282540
0
I
By Fund
Series B Preferred Stock
2019-02-19
4
C
0
2500000
D
Common Stock
403629
0
I
By Fund
Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 ("Common Stock"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.
The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering..
The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
/s/ Morana Jovan-Embiricos
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for Globeways Holdings Limited
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for Globeways Holdings II Limited
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for F2 Capital I 2015 Limited
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for F2 Bioscience II 2017 Limited
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for F2 Capital I 2017 Limited
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for F2 MG Limited
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for F2-TPO Investments, LLC
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for F2 BBG LLC
2019-02-21
/s/ Rachel Hingham and Ivan Bedford for F2 Capital I 2019, LLC
2019-02-21